LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 35

Search options

  1. Article ; Online: Inflammation and neuronal gene expression changes differ in early versus late chronic traumatic encephalopathy brain.

    Labadorf, Adam / Agus, Filisia / Aytan, Nurgul / Cherry, Jonathan / Mez, Jesse / McKee, Ann / Stein, Thor D

    BMC medical genomics

    2023  Volume 16, Issue 1, Page(s) 49

    Abstract: Background: Our understanding of the molecular underpinnings of chronic traumatic encephalopathy (CTE) and its associated pathology in post-mortem brain is incomplete. Factors including years of play and genetic risk variants influence the extent of tau ...

    Abstract Background: Our understanding of the molecular underpinnings of chronic traumatic encephalopathy (CTE) and its associated pathology in post-mortem brain is incomplete. Factors including years of play and genetic risk variants influence the extent of tau pathology associated with disease expression, but how these factors affect gene expression, and whether those effects are consistent across the development of disease, is unknown.
    Methods: To address these questions, we conducted an analysis of the largest post-mortem brain CTE mRNASeq whole-transcriptome dataset available to date. We examined the genes and biological processes associated with disease by comparing individuals with CTE with control individuals with a history of repetitive head impacts that lack CTE pathology. We then identified genes and biological processes associated with total years of play as a measure of exposure, amount of tau pathology present at time of death, and the presence of APOE and TMEM106B risk variants. Samples were stratified into low and high pathology groups based on McKee CTE staging criteria to model early versus late changes in response to exposure, and the relative effects associated with these factors were compared between these groups.
    Results: Substantial gene expression changes were associated with severe disease for most of these factors, primarily implicating diverse, strongly involved neuroinflammatory and neuroimmune processes. In contrast, low pathology groups had many fewer genes and processes implicated and show striking differences for some factors when compared with severe disease. Specifically, gene expression associated with amount of tau pathology showed a nearly perfect inverse relationship when compared between these two groups.
    Conclusions: Together, these results suggest the early CTE disease process may be mechanistically different than what occurs in late stages, that total years of play and tau pathology influence disease expression differently, and that related pathology-modifying risk variants may do so via distinct biological pathways.
    MeSH term(s) Humans ; Chronic Traumatic Encephalopathy/genetics ; Chronic Traumatic Encephalopathy/metabolism ; Chronic Traumatic Encephalopathy/pathology ; tau Proteins/genetics ; tau Proteins/metabolism ; Brain/metabolism ; Inflammation/metabolism ; Transcriptome ; Membrane Proteins/genetics ; Nerve Tissue Proteins/genetics
    Chemical Substances tau Proteins ; TMEM106B protein, human ; Membrane Proteins ; Nerve Tissue Proteins
    Language English
    Publishing date 2023-03-09
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2411865-5
    ISSN 1755-8794 ; 1755-8794
    ISSN (online) 1755-8794
    ISSN 1755-8794
    DOI 10.1186/s12920-023-01471-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.

    Blusztajn, Jan Krzysztof / Aytan, Nurgul / Rajendiran, Thekkelnaycke / Mellott, Tiffany J / Soni, Tanu / Burant, Charles F / Serrano, Geidy E / Beach, Thomas G / Lin, Honghuang / Stein, Thor D

    Journal of Alzheimer's disease : JAD

    2023  Volume 95, Issue 4, Page(s) 1623–1634

    Abstract: Background: Multiple studies have reported brain lipidomic abnormalities in Alzheimer's disease (AD) that affect glycerophospholipids, sphingolipids, and fatty acids. However, there is no consensus regarding the nature of these abnormalities, and it is ... ...

    Abstract Background: Multiple studies have reported brain lipidomic abnormalities in Alzheimer's disease (AD) that affect glycerophospholipids, sphingolipids, and fatty acids. However, there is no consensus regarding the nature of these abnormalities, and it is unclear if they relate to disease progression.
    Objective: Monogalactosyl diglycerides (MGDGs) are a class of lipids which have been recently detected in the human brain. We sought to measure their levels in postmortem human brain and determine if these levels correlate with the progression of the AD-related traits.
    Methods: We measured MGDGs by ultrahigh performance liquid chromatography tandem mass spectrometry in postmortem dorsolateral prefrontal cortex gray matter and subcortical corona radiata white matter samples derived from three cohorts of participants: the Framingham Heart Study, the Boston University Alzheimer's Disease Research Center, and the Arizona Study of Aging and Neurodegenerative Disorders/Brain and Body Donation Program (total n = 288).
    Results: We detected 40 molecular species of MGDGs (including diacyl and alkyl/acyl compounds) and found that the levels of 29 of them, as well as total MGDG levels, are positively associated with AD-related traits including pathologically confirmed AD diagnosis, clinical dementia rating, Braak and Braak stage, neuritic plaque score, phospho-Tau AT8 immunostaining density, levels of phospho-Tau396 and levels of Aβ40. Increased MGDG levels were present in both gray and white matter, indicating that they are widespread and likely associated with myelin-producing oligodendrocytes-the principal cell type of white matter.
    Conclusions: Our data implicate the MGDG metabolic defect as a central correlate of clinical and pathological progression in AD.
    MeSH term(s) Humans ; Alzheimer Disease/pathology ; White Matter/pathology ; Diglycerides/metabolism ; Brain/pathology ; Aging/pathology ; Gray Matter/pathology ; Disease Progression
    Chemical Substances Diglycerides
    Language English
    Publishing date 2023-09-15
    Publishing country Netherlands
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1440127-7
    ISSN 1875-8908 ; 1387-2877
    ISSN (online) 1875-8908
    ISSN 1387-2877
    DOI 10.3233/JAD-230543
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Vascular injury is associated with repetitive head impacts and tau pathology in chronic traumatic encephalopathy.

    Kirsch, Daniel / Shah, Arsal / Dixon, Erin / Kelley, Hunter / Cherry, Jonathan D / Xia, Weiming / Daley, Sarah / Aytan, Nurgul / Cormier, Kerry / Kubilus, Carol / Mathias, Rebecca / Alvarez, Victor E / Huber, Bertrand R / McKee, Ann C / Stein, Thor D

    Journal of neuropathology and experimental neurology

    2023  Volume 82, Issue 2, Page(s) 127–139

    Abstract: Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease linked to repetitive head impacts (RHI) and characterized by perivascular hyperphosphorylated tau (p-tau) deposits. The role of vascular injury, blood-brain barrier leakage, and ... ...

    Abstract Chronic traumatic encephalopathy (CTE) is a neurodegenerative disease linked to repetitive head impacts (RHI) and characterized by perivascular hyperphosphorylated tau (p-tau) deposits. The role of vascular injury, blood-brain barrier leakage, and neuroinflammation in CTE pathogenesis is not well understood. We performed quantitative immunoassays for intercellular adhesion molecule 1 (ICAM1), vascular cellular adhesion molecule 1 (VCAM1), and C-reactive protein (CRP) within the postmortem dorsolateral frontal cortex of participants with and without a history of RHI and CTE (n = 156), and tested for associations with RHI, microgliosis, and tau pathology measures. Levels of vascular injury-associated markers ICAM1, VCAM1, and CRP were increased in CTE compared to RHI-exposed and -naïve controls. ICAM1 and CRP increased with RHI exposure duration (p < 0.01) and were associated with increased microglial density (p < 0.001) and tau pathology (AT8, p-tau396, p-tau202; p < 0.05). Histologically, there was significantly increased ICAM1 staining of the microvasculature, extracellular space, and astrocytes at the sulcal depths in high stage CTE compared to both low stage CTE and controls. Multifocal perivascular immunoreactivity for serum albumin was present in all RHI-exposed individuals. These findings demonstrate that vascular injury markers are associated with RHI exposure, duration, and microgliosis, are elevated in CTE, and increase with disease severity.
    MeSH term(s) Humans ; Chronic Traumatic Encephalopathy/pathology ; Neurodegenerative Diseases ; Vascular System Injuries/complications ; Frontal Lobe/metabolism ; Blood-Brain Barrier/pathology ; tau Proteins/metabolism
    Chemical Substances tau Proteins
    Language English
    Publishing date 2023-01-08
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 3088-0
    ISSN 1554-6578 ; 0022-3069
    ISSN (online) 1554-6578
    ISSN 0022-3069
    DOI 10.1093/jnen/nlac122
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer's disease.

    Carreras, Isabel / Aytan, Nurgul / Choi, Ji-Kyung / Tognoni, Christina M / Kowall, Neil W / Jenkins, Bruce G / Dedeoglu, Alpaslan

    Scientific reports

    2019  Volume 9, Issue 1, Page(s) 10972

    Abstract: Lipid metabolism is abnormal in Alzheimer's disease (AD) brain leading to ceramide and sphingosine accumulation and reduced levels of brain sphingosine-1-phosphate (S1P). We hypothesize that changes in S1P signaling are central to the inflammatory and ... ...

    Abstract Lipid metabolism is abnormal in Alzheimer's disease (AD) brain leading to ceramide and sphingosine accumulation and reduced levels of brain sphingosine-1-phosphate (S1P). We hypothesize that changes in S1P signaling are central to the inflammatory and immune-pathogenesis of AD and the therapeutic benefits of fingolimod, a structural analog of sphingosine that is FDA approved for the treatment of multiple sclerosis. We recently reported that the neuroprotective effects of fingolimod in 5xFAD transgenic AD mice treated from 1-3 months of age were greater at 1 mg/kg/day than at 5 mg/kg/day. Here we performed a dose-response study using fingolimod from 0.03 to 1 mg/kg/day in 5xFAD mice treated from 1-8 months of age. At 1 mg/kg/day, fingolimod decreased both peripheral blood lymphocyte counts and brain Aβ levels, but at the lowest dose tested (0.03 mg/kg/day), we detected improved memory, decreased activation of brain microglia and astrocytes, and restored hippocampal levels of GABA and glycerophosphocholine with no effect on circulating lymphocyte counts. These findings suggests that, unlike the case in multiple sclerosis, fingolimod may potentially have therapeutic benefits in AD at low doses that do not affect peripheral lymphocyte function.
    MeSH term(s) Alzheimer Disease/drug therapy ; Amyloid beta-Peptides/metabolism ; Animals ; Astrocytes/drug effects ; Astrocytes/pathology ; Brain/drug effects ; Brain/pathology ; Disease Models, Animal ; Drug Repositioning ; Female ; Fingolimod Hydrochloride/administration & dosage ; Fingolimod Hydrochloride/therapeutic use ; Mice ; Mice, Transgenic ; Microglia/drug effects ; Microglia/pathology ; Neuroprotective Agents/administration & dosage ; gamma-Aminobutyric Acid/metabolism
    Chemical Substances Amyloid beta-Peptides ; Neuroprotective Agents ; gamma-Aminobutyric Acid (56-12-2) ; Fingolimod Hydrochloride (G926EC510T)
    Language English
    Publishing date 2019-07-29
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-019-47287-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Repetitive head impacts and chronic traumatic encephalopathy are associated with TDP-43 inclusions and hippocampal sclerosis.

    Nicks, Raymond / Clement, Nathan F / Alvarez, Victor E / Tripodis, Yorghos / Baucom, Zachery H / Huber, Bertrand R / Mez, Jesse / Alosco, Michael L / Aytan, Nurgul / Cherry, Jonathan D / Cormier, Kerry A / Kubilius, Carol / Mathias, Rebecca / Svirsky, Sarah E / Pothast, Morgan J / Hildebrandt, Audrey M / Chung, Jaeyoon / Han, Xudong / Crary, John F /
    McKee, Ann C / Frosch, Matthew P / Stein, Thor D

    Acta neuropathologica

    2023  Volume 145, Issue 4, Page(s) 395–408

    Abstract: Hippocampal sclerosis (HS) is associated with advanced age as well as transactive response DNA-binding protein with 43 kDa (TDP-43) deposits. Both hippocampal sclerosis and TDP-43 proteinopathy have also been described in chronic traumatic encephalopathy ...

    Abstract Hippocampal sclerosis (HS) is associated with advanced age as well as transactive response DNA-binding protein with 43 kDa (TDP-43) deposits. Both hippocampal sclerosis and TDP-43 proteinopathy have also been described in chronic traumatic encephalopathy (CTE), a neurodegenerative disease linked to exposure to repetitive head impacts (RHI). However, the prevalence of HS in CTE, the pattern of TDP-43 pathology, and associations of HS and TDP-43 with RHI are unknown. A group of participants with a history of RHI and CTE at autopsy (n = 401) as well as a group with HS-aging without CTE (n = 33) was examined to determine the prevalence of HS and TDP-43 inclusions in CTE and to compare the clinical and pathological features of HS and TDP-43 inclusions in CTE to HS-aging. In CTE, HS was present in 23.4%, and TDP-43 inclusions were present in 43.3% of participants. HS in CTE occurred at a relatively young age (mean 77.0 years) and was associated with a greater number of years of RHI than CTE without HS adjusting for age (p = 0.029). In CTE, TDP-43 inclusions occurred frequently in the frontal cortex and occurred both with and without limbic TDP-43. Additionally, structural equation modeling demonstrated that RHI exposure years were associated with hippocampal TDP-43 inclusions (p < 0.001) through increased CTE stage (p < 0.001). Overall, RHI and the development of CTE pathology may contribute to TDP-43 deposition and hippocampal sclerosis.
    MeSH term(s) Humans ; Aged ; Chronic Traumatic Encephalopathy/pathology ; Neurodegenerative Diseases ; Hippocampal Sclerosis ; Aging ; TDP-43 Proteinopathies/pathology ; DNA-Binding Proteins/metabolism
    Chemical Substances DNA-Binding Proteins
    Language English
    Publishing date 2023-01-21
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S. ; Research Support, Non-U.S. Gov't
    ZDB-ID 1079-0
    ISSN 1432-0533 ; 0001-6322
    ISSN (online) 1432-0533
    ISSN 0001-6322
    DOI 10.1007/s00401-023-02539-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Vasoactive Intestinal Peptide Decreases β-Amyloid Accumulation and Prevents Brain Atrophy in the 5xFAD Mouse Model of Alzheimer's Disease.

    Korkmaz, Orhan Tansel / Ay, Hakan / Aytan, Nurgul / Carreras, Isabel / Kowall, Neil W / Dedeoglu, Alpaslan / Tuncel, Nese

    Journal of molecular neuroscience : MN

    2018  Volume 68, Issue 3, Page(s) 389–396

    Abstract: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular deposits of fibrillary β-amyloid (Aβ) plaques in the brain that initiate an inflammatory process resulting in neurodegeneration. The neuronal loss associated with AD ... ...

    Abstract Alzheimer's disease (AD) is a neurodegenerative disorder characterized by extracellular deposits of fibrillary β-amyloid (Aβ) plaques in the brain that initiate an inflammatory process resulting in neurodegeneration. The neuronal loss associated with AD results in gross atrophy of affected regions causing a progressive loss of cognitive ability and memory function, ultimately leading to dementia. Growing evidence suggests that vasoactive intestinal peptide (VIP) could be beneficial for various neurodegenerative diseases, including AD. The study investigated the effects of VIP on 5xFAD, a transgenic mouse model of AD. Toward this aim, we used 20 5xFAD mice in two groups (n = 10 each), VIP-treated (25 ng/kg i.p. injection, three times per week) and saline-treated (the drug's vehicle) following the same administration regimen. Treatment started at 1 month of age and ended 2 months later. After 2 months of treatment, the mice were euthanized, their brains dissected out, and immunohistochemically stained for Aβ
    MeSH term(s) Alzheimer Disease/drug therapy ; Amyloid beta-Peptides/metabolism ; Animals ; Atrophy/drug therapy ; Brain/drug effects ; Brain/pathology ; Female ; Mice ; Neuroprotective Agents/administration & dosage ; Neuroprotective Agents/pharmacology ; Neuroprotective Agents/therapeutic use ; Vasoactive Intestinal Peptide/administration & dosage ; Vasoactive Intestinal Peptide/pharmacology ; Vasoactive Intestinal Peptide/therapeutic use
    Chemical Substances Amyloid beta-Peptides ; Neuroprotective Agents ; Vasoactive Intestinal Peptide (37221-79-7)
    Language English
    Publishing date 2018-11-29
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1043392-2
    ISSN 1559-1166 ; 0895-8696
    ISSN (online) 1559-1166
    ISSN 0895-8696
    DOI 10.1007/s12031-018-1226-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Protective effects of 7,8-dihydroxyflavone on neuropathological and neurochemical changes in a mouse model of Alzheimer's disease.

    Aytan, Nurgul / Choi, Ji-Kyung / Carreras, Isabel / Crabtree, Leah / Nguyen, Brian / Lehar, Margaret / Blusztajn, Jan Krzysztof / Jenkins, Bruce G / Dedeoglu, Alpaslan

    European journal of pharmacology

    2018  Volume 828, Page(s) 9–17

    Abstract: Interest in brain-derived neurotrophic factor (BDNF) was greatly enhanced when it was recognized that its expression is reduced in neurodegenerative disorders, especially in Alzheimer's disease (AD). BDNF signaling through the TrkB receptor has a central ...

    Abstract Interest in brain-derived neurotrophic factor (BDNF) was greatly enhanced when it was recognized that its expression is reduced in neurodegenerative disorders, especially in Alzheimer's disease (AD). BDNF signaling through the TrkB receptor has a central role in promoting synaptic transmission, synaptogenesis, and facilitating synaptic plasticity making the BDNF-TrkB signaling pathway an attractive candidate for targeted therapies. Here we investigated the early effect of the small molecule TrkB agonist, 7,8 dihydroxyflavone (7,8-DHF), on AD-related pathology, dendritic arborization, synaptic density, and neurochemical changes in the 5xFAD mouse model of AD. We treated 5xFAD mice with 7,8-DHF for 2 months beginning at 1 month of age. We found that, in this model of AD, 7,8-DHF treatment decreased cortical Aβ plaque deposition and protected cortical neurons against reduced dendritic arbor complexity but had no significant impact on the density of dendritic spines. In addition 7,8-DHF treatment protected against hippocampal increase in the level of choline-containing compounds and glutamate loss, but had no significant impact on hippocampal neurogenesis.
    MeSH term(s) Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Amyloid beta-Peptides/metabolism ; Animals ; Dendritic Spines/drug effects ; Dendritic Spines/pathology ; Disease Models, Animal ; Flavones/pharmacology ; Hippocampus/drug effects ; Hippocampus/metabolism ; Hippocampus/pathology ; Mice ; Neuroprotective Agents/pharmacology ; Peptide Fragments/metabolism
    Chemical Substances 6,7-dihydroxyflavone ; Amyloid beta-Peptides ; Flavones ; Neuroprotective Agents ; Peptide Fragments ; amyloid beta-protein (1-40) ; amyloid beta-protein (1-42)
    Language English
    Publishing date 2018-03-03
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 80121-5
    ISSN 1879-0712 ; 0014-2999
    ISSN (online) 1879-0712
    ISSN 0014-2999
    DOI 10.1016/j.ejphar.2018.02.045
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Developmental delays and psychiatric diagnoses are elevated in offspring staying in prisons with their mothers.

    Kutuk, Meryem Ozlem / Altintas, Ebru / Tufan, Ali Evren / Guler, Gulen / Aslan, Betul / Aytan, Nurgul / Kutuk, Ozgur

    Scientific reports

    2018  Volume 8, Issue 1, Page(s) 1856

    Abstract: The aim of the study was to describe the sociodemographic and clinical features of the mothers and their offspring staying with them in prison. The study was planned as a cross-sectional, single-center study of mothers residing in Tarsus Closed Women's ... ...

    Abstract The aim of the study was to describe the sociodemographic and clinical features of the mothers and their offspring staying with them in prison. The study was planned as a cross-sectional, single-center study of mothers residing in Tarsus Closed Women's Prison of Turkish Ministry of Justice along with their 0 to 6 years old offspring. Mothers were evaluated via Structured Clinical Interview for DSM-IV Axis I Disorders. A psychologist blind to maternal evaluations applied the Denver Developmental Screening Test II (DII-DST). Children/mothers were also evaluated by a child and adolescent psychiatrist via K-SADS-PL. Twenty-four mothers with a mean age of 29.3 years were included. Most common diagnoses in mothers were nicotine abuse (n = 17, 70.8%), specific phobia (n = 8, 33.3%), alcohol abuse (n = 7, 29.2%) and substance abuse (n = 5, 20.8%). Twenty-six children (53.9% female) were living with their mothers in prison, and the mean age of those was 26.3 months. Results of the D-II-DST were abnormal in 33.3% of the children. Most common diagnoses in children were adjustment disorder (n = 7, 26.9%) separation anxiety disorder (n = 3, 11.5%) and conduct disorder (n = 2, 7.7%). A multi-center study is necessary to reach that neglected/under-served population and address the inter-generational transmission of abuse, neglect, and psychopathology.
    MeSH term(s) Adolescent ; Adult ; Child ; Child of Impaired Parents/psychology ; Child of Impaired Parents/statistics & numerical data ; Child, Preschool ; Cross-Sectional Studies ; Developmental Disabilities/diagnosis ; Developmental Disabilities/epidemiology ; Developmental Disabilities/psychology ; Diagnostic and Statistical Manual of Mental Disorders ; Female ; Humans ; Infant ; Infant, Newborn ; Male ; Mothers/psychology ; Mothers/statistics & numerical data ; Prisons ; Psychometrics/methods ; Turkey/epidemiology ; Young Adult
    Language English
    Publishing date 2018-01-30
    Publishing country England
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-018-20263-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Associations between brain inflammatory profiles and human neuropathology are altered based on apolipoprotein E ε4 genotype.

    Friedberg, Jacob S / Aytan, Nurgul / Cherry, Jonathan D / Xia, Weiming / Standring, Oliver J / Alvarez, Victor E / Nicks, Raymond / Svirsky, Sarah / Meng, Gaoyuan / Jun, Gyungah / Ryu, Hoon / Au, Rhoda / Stein, Thor D

    Scientific reports

    2020  Volume 10, Issue 1, Page(s) 2924

    Abstract: Alzheimer disease (AD) is a chronic neurodegenerative disease with a multitude of contributing genetic factors, many of which are related to inflammation. The apolipoprotein E (APOE) ε4 allele is the most common genetic risk factor for AD and is related ... ...

    Abstract Alzheimer disease (AD) is a chronic neurodegenerative disease with a multitude of contributing genetic factors, many of which are related to inflammation. The apolipoprotein E (APOE) ε4 allele is the most common genetic risk factor for AD and is related to a pro-inflammatory state. To test the hypothesis that microglia and AD-implicated cytokines were differentially associated with AD pathology based on the presence of APOE ε4, we examined the dorsolateral frontal cortex from deceased participants within a community-based aging cohort (n = 154). Cellular density of Iba1, a marker of microglia, was positively associated with tau pathology only in APOE ε4 positive participants (p = 0.001). The cytokines IL-10, IL-13, IL-4, and IL-1α were negatively associated with tau pathology, independent of Aβ
    MeSH term(s) Aged, 80 and over ; Alleles ; Amyloid beta-Peptides/metabolism ; Antigens, CD/metabolism ; Antigens, Differentiation, Myelomonocytic/metabolism ; Apolipoprotein E4/genetics ; Biomarkers/metabolism ; Brain/pathology ; Calcium-Binding Proteins/metabolism ; Cell Count ; Cohort Studies ; Cytokines/metabolism ; Dementia/pathology ; Female ; Genotype ; Humans ; Inflammation/genetics ; Inflammation/pathology ; Male ; Microfilament Proteins/metabolism ; Microglia/metabolism ; Microglia/pathology ; Models, Biological ; tau Proteins/metabolism
    Chemical Substances AIF1 protein, human ; Amyloid beta-Peptides ; Antigens, CD ; Antigens, Differentiation, Myelomonocytic ; Apolipoprotein E4 ; Biomarkers ; CD68 antigen, human ; Calcium-Binding Proteins ; Cytokines ; Microfilament Proteins ; tau Proteins
    Language English
    Publishing date 2020-02-19
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-020-59869-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: MicroRNA Alterations in Chronic Traumatic Encephalopathy and Amyotrophic Lateral Sclerosis.

    Alvia, Marcela / Aytan, Nurgul / Spencer, Keith R / Foster, Zachariah W / Rauf, Nazifa Abdul / Guilderson, Latease / Robey, Ian / Averill, James G / Walker, Sean E / Alvarez, Victor E / Huber, Bertrand R / Mathais, Rebecca / Cormier, Kerry A / Nicks, Raymond / Pothast, Morgan / Labadorf, Adam / Agus, Filisia / Alosco, Michael L / Mez, Jesse /
    Kowall, Neil W / McKee, Ann C / Brady, Christopher B / Stein, Thor D

    Frontiers in neuroscience

    2022  Volume 16, Page(s) 855096

    Abstract: Repetitive head impacts (RHI) and traumatic brain injuries are risk factors for the neurodegenerative diseases chronic traumatic encephalopathy (CTE) and amyotrophic lateral sclerosis (ALS). ALS and CTE are distinct disorders, yet in some instances, ... ...

    Abstract Repetitive head impacts (RHI) and traumatic brain injuries are risk factors for the neurodegenerative diseases chronic traumatic encephalopathy (CTE) and amyotrophic lateral sclerosis (ALS). ALS and CTE are distinct disorders, yet in some instances, share pathology, affect similar brain regions, and occur together. The pathways involved and biomarkers for diagnosis of both diseases are largely unknown. MicroRNAs (miRNAs) involved in gene regulation may be altered in neurodegeneration and be useful as stable biomarkers. Thus, we set out to determine associations between miRNA levels and disease state within the prefrontal cortex in a group of brain donors with CTE, ALS, CTE + ALS and controls. Of 47 miRNAs previously implicated in neurological disease and tested here, 28 (60%) were significantly different between pathology groups. Of these, 21 (75%) were upregulated in both ALS and CTE, including miRNAs involved in inflammatory, apoptotic, and cell growth/differentiation pathways. The most significant change occurred in miR-10b, which was significantly increased in ALS, but not CTE or CTE + ALS. Overall, we found patterns of miRNA expression that are common and unique to CTE and ALS and that suggest shared and distinct mechanisms of pathogenesis.
    Language English
    Publishing date 2022-05-19
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2411902-7
    ISSN 1662-453X ; 1662-4548
    ISSN (online) 1662-453X
    ISSN 1662-4548
    DOI 10.3389/fnins.2022.855096
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top